Summit VetPharm

Summit VetPharm operated as a manufacturer and distributor of animal health products, with a specific focus on ectoparasiticidal topicals for companion animals. The company was established in 2006 and headquartered in Rutherford, New Jersey. It was initially founded by veterinarians and experienced industry professionals as a subsidiary of the Japanese conglomerate Sumitomo Corp. Summit VetPharm's primary mission was to serve the companion animal veterinary sector.

The company's business model centered on the exclusive distribution of its products through licensed veterinarians, a strategy that distinguished it within the competitive parasiticide market. Revenue was generated from the sale of its flagship product line, Vectra, to veterinary practices. To enforce its veterinarian-exclusive sales channel, Summit VetPharm utilized a tracking system called "Bloodhound" Technology, which monitored product packages from manufacturing to the final veterinary purchase, preventing diversion to online pharmacies or retail stores.

The core of Summit VetPharm's offering was the Vectra brand of topical treatments for dogs and cats. Key products included Vectra 3D for dogs, which provided protection against fleas, ticks, mosquitoes, lice, mites, and sand flies. Other formulations, Vectra for dogs and puppies and Vectra for cats and kittens, targeted flea control. The active insecticidal ingredient in the Vectra line was dinotefuran, a third-generation neonicotinoid. The company's market debut in 2007 with the Vectra brand quickly gained significant market share.

A significant milestone in the company's history occurred in August 2010, when it was acquired by the French veterinary pharmaceutical company Ceva Santé Animale. Ceva acquired a 70 percent majority share, while Sumitomo Corp. retained a 30 percent interest, continuing its investment in the animal health sector. Following the acquisition, Summit VetPharm was integrated into Ceva's U.S. operations, based in Lenexa, Kansas, strengthening Ceva's position in the U.S. companion animal market by giving it entry into the flea and tick control segment.

Keywords: Summit VetPharm, Ceva Santé Animale, Sumitomo Corp, veterinary pharmaceuticals, animal health, Vectra 3D, parasite control, flea and tick, dinotefuran, ectoparasiticides, veterinarian-dispensed, companion animals, Bloodhound Technology, animal parasiticides, pet health, topical treatments, veterinary medicine, neonicotinoid, veterinary distribution, pet medication